Displaying drugs 13301 - 13325 of 15194 in total
PHENYLAMINOIMIDAZO(1,2-ALPHA)PYRIDINE
Experimental
BMS-777607
BMS-777607 has been investigated for the basic science of Malignant Solid Tumour.
Investigational
2-AMINO-4-CHLORO-3-HYDROXYBENZOIC ACID
Experimental
RO7300490
RO7300490 is an investigational Fibroblast Activation Protein-α (FAP) targeted CD40 agonist. RO7300490 is under investigation in clinical trial NCT04857138 (A Study to Evaluate Safety, Pharmacokinetics and Anti-tumor Activity of RO7300490, as Single Agent or in Combination With Atezolizumab in Participants With Advanced Solid Tumors).
Investigational
Matched Description: … is under investigation in clinical trial NCT04857138 (A Study to Evaluate Safety, Pharmacokinetics and …
FB-825
FB-825 is an investigational humanized monoclonal antibody that targets the CεmX domain of the membrane-bound IgE (mIgE), causing a depletion of mIgE positive B-cells. It is currently being investigated for immune disorders, such as atopic dermatitis and hyperimmunoglobulin E syndrome (HIES).[A258448,L45743]
Investigational
Matched Description: … It is currently being investigated for immune disorders, such as atopic dermatitis and hyperimmunoglobulin …
Indalpine
Indalpine was one of the first selective serotonin reuptake inhibitors to reach the American market. It was initially marketed by Pharmuka. However, after the emergence of widespread concern regarding adverse effects caused by SSRIs, and reported hematological effects caused by Indalpine, it was abruptly withdrawn from the US market.
Investigational
Withdrawn
Matched Description: … However, after the emergence of widespread concern regarding adverse effects caused by SSRIs, and reported …
IL15-NK Cell
Natural killer (NK) cells can be incubated with ‘feeder cells’ expressing certain cytokines prior to maturation to enhance their activity. In particular, incubation with IL-15 allows NK cells to lyse a broad range of fresh and cultured tumor targets that the cell is not normally sensitive to.
Investigational
Matched Description: … In particular, incubation with IL-15 allows NK cells to lyse a broad range of fresh and cultured tumor …
ATG-101
ATG-101 is a novel PD-L1/4-1BB bispecific antibody that was designed to block the binding of immunosuppressive PD-1/PD-L1 and conditionally induce 4-1BB stimulation, thus activating anti-tumor immune effectors, while delivering enhanced anti-tumor activity, with an improved safety profile.
Investigational
Matched Description: … PD-L1/4-1BB bispecific antibody that was designed to block the binding of immunosuppressive PD-1/PD-L1 and …
2,3-Dihydroxy-Benzoic Acid
Experimental
N-Benzyl-4-Sulfamoyl-Benzamide
Experimental
Dihydrouracil
Experimental
Isopropyl beta-D-thiogalactopyranoside
A non-metabolizable galactose analog that induces expression of the LAC operon.
Experimental
1,4-dithio-alpha-D-glucopyranose
Experimental
2-deoxy-2-acetamido-beta-D-galactose-4-sulfate
Experimental
alpha-D-glucose 6-phosphate
Experimental
2,5-Diaminopyrimidin-4,6-diol
Experimental
Ribose-5-phosphate
Experimental
2-deoxy-2-fluoro-β-D-galactose
Experimental
Maltotetraose
Experimental
Displaying drugs 13301 - 13325 of 15194 in total